"
Team:HokkaidoU Japan/Safety
From 2011.igem.org
(→Safety proposal) |
|||
| Line 1: | Line 1: | ||
| - | {{ | + | {{Team:HokkaidoU_Japan/header}} |
==Safety proposal== | ==Safety proposal== | ||
| Line 7: | Line 7: | ||
* environmental safety? | * environmental safety? | ||
| - | + | Our study will not contain any manipulation associated with pathogenic bacteria, live salmonella bacteria. Although we are planning to use a part of Salmonella's genome which was obtained from Salmonella Genetic Stock Centre (SGSC), our instructor obtained appropriate permission from the safety officer of genetic recombination (SOOGR) in our university. These E. coli were acknowledged as non-pathogenic and permitted to be used under P1 safety level. | |
| - | + | Permit for using particular parts of Salmonella's genome library was obtained on the basis that genetic information encoded in them is not sufficient to express pathogenicity in E. coli. | |
| - | + | Our lab is equipped appropriately for the manipulation and genetic recombination of bacterial cells. Team members are instructed according to the safety training manual. | |
| Line 19: | Line 19: | ||
* How could other teams learn from your experience? | * How could other teams learn from your experience? | ||
| - | + | Currently there are no BioBricks which raise any safety issues. | |
| Line 26: | Line 26: | ||
* If no, which specific biosafety rules or guidelines do you have to consider in your country? | * If no, which specific biosafety rules or guidelines do you have to consider in your country? | ||
| - | + | We have “the Safety Office of Genetic Recombination in Hokkaido University”. | |
4. Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering? | 4. Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering? | ||
| - | + | Currently we don't have any suggestions. | |
<!-- | <!-- | ||
| Line 42: | Line 42: | ||
* Risks to security through malicious misuse by individuals, groups or states? | * Risks to security through malicious misuse by individuals, groups or states? | ||
| - | + | We are using following parts of salmonella genome library. | |
BAC clones of S. Typhimurium, | BAC clones of S. Typhimurium, | ||
B_STM02P01 SGSC4014 837453-941863 | B_STM02P01 SGSC4014 837453-941863 | ||
| Line 61: | Line 61: | ||
--> | --> | ||
| - | {{ | + | {{Team:HokkaidoU_Japan/footer}} |
Revision as of 09:08, 2 October 2011
HokkaidoU Japan
iGEM 2011 Team of Hokkaido University
Contents |
Safety proposal
1. Would any of your project ideas raise safety issues in terms of:
- researcher safety,
- public safety, or
- environmental safety?
Our study will not contain any manipulation associated with pathogenic bacteria, live salmonella bacteria. Although we are planning to use a part of Salmonella's genome which was obtained from Salmonella Genetic Stock Centre (SGSC), our instructor obtained appropriate permission from the safety officer of genetic recombination (SOOGR) in our university. These E. coli were acknowledged as non-pathogenic and permitted to be used under P1 safety level.
Permit for using particular parts of Salmonella's genome library was obtained on the basis that genetic information encoded in them is not sufficient to express pathogenicity in E. coli.
Our lab is equipped appropriately for the manipulation and genetic recombination of bacterial cells. Team members are instructed according to the safety training manual.
2. Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? If yes,
- did you document these issues in the Registry?
- how did you manage to handle the safety issue?
- How could other teams learn from your experience?
Currently there are no BioBricks which raise any safety issues.
3. Is there a local biosafety group, committee, or review board at your institution?
- If yes, what does your local biosafety group think about your project?
- If no, which specific biosafety rules or guidelines do you have to consider in your country?
We have “the Safety Office of Genetic Recombination in Hokkaido University”.
4. Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering?
Currently we don't have any suggestions.
